CME Group Inc. (NASDAQ:CME) Shares Sold by Joel Isaacson & Co. LLC

Joel Isaacson & Co. LLC trimmed its holdings in CME Group Inc. (NASDAQ:CME) by 16.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,210 shares of the financial services provider’s stock after selling 245 shares during the period. Joel Isaacson & Co. LLC’s holdings in CME Group were worth $267,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. CVA Family Office LLC grew its position in shares of CME Group by 11.8% in the third quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock valued at $96,000 after purchasing an additional 46 shares during the last quarter. Capital Advisors Ltd. LLC lifted its stake in CME Group by 4.3% in the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after buying an additional 48 shares in the last quarter. Lester Murray Antman dba SimplyRich grew its holdings in CME Group by 0.7% during the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after buying an additional 50 shares during the last quarter. Essex LLC increased its position in CME Group by 3.3% during the first quarter. Essex LLC now owns 1,649 shares of the financial services provider’s stock worth $355,000 after buying an additional 52 shares in the last quarter. Finally, Quent Capital LLC increased its position in CME Group by 10.2% during the third quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock worth $131,000 after buying an additional 55 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Stock Performance

CME Group stock opened at $226.14 on Friday. The company has a market cap of $81.43 billion, a price-to-earnings ratio of 25.73, a price-to-earnings-growth ratio of 7.76 and a beta of 0.55. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.36. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The stock’s 50-day moving average is $218.94 and its 200-day moving average is $208.89.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter last year, the firm posted $2.25 earnings per share. CME Group’s revenue for the quarter was up 18.4% compared to the same quarter last year. Equities analysts anticipate that CME Group Inc. will post 10.04 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were issued a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.03%. CME Group’s payout ratio is 52.33%.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Keefe, Bruyette & Woods increased their price objective on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research note on Thursday, July 25th. JPMorgan Chase & Co. lifted their price target on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Royal Bank of Canada reissued a “sector perform” rating and set a $235.00 price objective on shares of CME Group in a research note on Thursday. Barclays lifted their target price on shares of CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research note on Thursday. Finally, Bank of America increased their price target on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research note on Thursday, October 3rd. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company. According to MarketBeat, CME Group presently has an average rating of “Hold” and an average target price of $222.07.

Insider Buying and Selling

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is owned by corporate insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.